Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients

Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients

BackgroundThis study compared the glycemic effectiveness of three metformin-based dual therapies according to baseline hemoglobin A1c (HbA1c) to evaluate the appropriateness of the guideline enforced by the National Health Insurance Corporation of Korea for initial medication of type 2 diabetes (T2D...

Full description

Bibliographic Details
Main Authors:	Young Ki Lee, Sun Ok Song, Kwang Joon Kim, Yongin Cho, Younjeong Choi, Yujung Yun, Byung-Wan Lee, Eun-Seok Kang, Bong Soo Cha, Hyun Chul Lee
Format:	Article
Language:	English
Published:	Korean Diabetes Association 2013-12-01
Series:	Diabetes & Metabolism Journal
Subjects:	Diabetes mellitus, type 2 Metformin Pioglitazone Sitagliptin Sulphonylurea
Online Access:	http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-37-465.pdf

Similar Items

Single Nucleotide Polymorphisms Associated with Metformin and Sulphonylureas’ Glycaemic Response among South African Adults with Type 2 Diabetes Mellitus
by: Charity Masilela, et al.
Published: (2021-02-01)

Combination therapy with DPP-4 inhibitors and pioglitazone in type 2 diabetes: theoretical consideration and therapeutic potential
by: Nasser Mikhail
Published: (2008-12-01)

Combined pioglitazone–metformin and clomiphene citrate versus metformin and clomiphene citrate in induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome
by: Ghada Abdel Fattah, et al.
Published: (2014-03-01)

Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
by: Karoon Shahebrahimi, et al.
Published: (2016-01-01)

Modern sulphonylureas and cardiovascular adverse effects: Will CAROLINA put an end to the controversy?
by: Mathew John, et al.
Published: (2020-07-01)

Metformin and Pioglitazone Reduce Gene Expression of Inflammatory Factors in Insulin Resistant and Hypertrophied Adipocytes
by: Zahra Malekpour-Dehkordi, et al.
Published: (2020-12-01)

Inhibition of P-glycoprotein expression and function by anti-diabetic drugs gliclazide, metformin, and pioglitazone in vitro and in situ
by: Mehran Mesgari Abbasi, et al.
Published: (2016-01-01)

Multivariate Chemometric Assisted Analysis of Metformin Hydrochloride, Gliclazide and Pioglitazone Hydrochloride in Bulk Drug and Dosage Forms
by: Vipin Saini, et al.
Published: (2013-02-01)

Efficacy of Early Combined Therapy with Metformin and Pioglitazone in Patients with Diabetes Mellitus Type 2
by: V.I. Pankiv
Published: (2012-03-01)

Neonatal Diabetes Caused by Activating Mutations in the Sulphonylurea Receptor
by: Peter Proks
Published: (2013-06-01)

Effects of Pioglitazone and Metformin on Insulin Resistance Reduction in Polycystic Ovary Syndrome: A Comparative Study
by: Amir Ziaie, et al.
Published: (2012-03-01)

Diabetes mellitus in the young: Gliptins or sulfonylurea after metformin?
by: J Muthukrishnan, et al.
Published: (2012-01-01)

Comparison Between Pioglitazone/Metformin Combination Therapy and Sitagliptin/Metformin Combination Therapy on the Efficacy in Chinese Type 2 Diabetic Adults Insufficiently Controlled with Metformin: Study Protocol of an Open-Label, Multicenter, Non-Inferiority Parallel-Group Randomized Controlled Trial
by: Zhang F, et al.
Published: (2021-03-01)

New combination treatments in the management of diabetes: focus on sitagliptin – metformin
by: Jennifer Green, et al.
Published: (2008-08-01)

Successful transition to sulphonylurea therapy from insulin in a child with permanent neonatal diabetes due to a KCNJ11 gene mutation
by: Venkatesan Radha, et al.
Published: (2018-01-01)

A Comparison of the Therapeutic Effects of Metformin, Pioglitazone and Vitamin E in Patients with Non-Alcoholic Fatty Liver
by: K Shahebrahimi, et al.
Published: (2017-09-01)

Combination treatment for type 2 diabetes mellitus (T2DM) : dipeptidyl peptidase-4 inhibitors (DPP-4) and metformin
by: Erna Kristin
Published: (2017-10-01)

Impact of Metformin and Pioglitazone on Serum Level of Tumor Necrosis Factor-Alpha and Lipid Profiles during Implantation Window in Diabetic Rats
by: Abbas Bakhteyari, et al.
Published: (2019-07-01)

Development and validation of RP HPLC method for determination of metformin and sitagliptin in bulk and pharmaceutical dosage form
by: Kavitha D., et al.
Published: (2017-04-01)

Combination Therapy of Nifedipine and Sulphonylureas Exhibits a Mutual Antagonistic Effect on the Endothelial Cell Dysfunction Induced by Hyperglycemia Linked to Vascular Disease
by: Li-Ping Wang, et al.
Published: (2016-05-01)

A Case of Janumet Poisoning
by: Arun Bahulikar, et al.
Published: (2017-11-01)

Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
by: Alexander Sergeevich Ametov, et al.
Published: (2010-09-01)

Efficiency and Safety of Metformine and Pioglitazone in Patients with Coronary Heart Disease and Diabetes Mellitus Type 2
by: Z.A. Shaienko, et al.
Published: (2015-03-01)

Influence of novel GPR119 agonist in combination with metformin and sitagliptin on glycemia, body weight and food intake in rats fed a high-fat diet
by: Ivan N. Tyurenkov, et al.
Published: (2019-12-01)

The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone
by: Sun Ok Song, et al.
Published: (2012-10-01)

BIOANALYTICAL METHOD BY COLUMN-SWITCHING WITH DIRECT INJECTION OF HUMAN PLASMA FOR DETERMINATION OF SULPHONYLUREAS
by: Juliana Veloso Ferreira, et al.
Published: (2019-07-01)

Retinoprotection by BGP-15, a Hydroximic Acid Derivative, in a Type II Diabetic Rat Model Compared to Glibenclamide, Metformin, and Pioglitazone
by: Zita Wachal, et al.
Published: (2020-03-01)

Sitagliptin 100 mg vs glimepiride 1–3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM)
by: Jothydev Kesavadev, et al.
Published: (2017-11-01)

Clomiphene citrate alone, in combination with metformin or in combination with pioglitazone as first line therapy in induction of ovulation in infertile women with polycystic ovary syndrome, a randomized controlled trial
by: Wessam Magdi Abuelghar, et al.
Published: (2013-09-01)

Experience with sitagliptin (the first DPP-4 inhibitor) application to the treatment of type 2 diabetes mellitus in the Russian Federation:Results of the DIA-DA observation program
by: Marina Vladimirovna Shestakova
Published: (2010-09-01)

Sitagliptin/metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy
by: Hayes J, et al.
Published: (2016-07-01)

Acarbose Add-on Therapy in Patients with Type 2 Diabetes Mellitus with Metformin and Sitagliptin Failure: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
by: Hae Kyung Yang, et al.
Published: (2019-06-01)

Anwendung der Trockenblutanalytik zur vereinfachten Überwachung der Nierenfunktion und zur Blutspiegelbestimmung von Metformin und Sitagliptin
by: Scherf-Clavel, Maike
Published: (2017)

Comparative evaluation of safety and efficacy of glimepiride and sitagliptin in combination with metformin in patients with type 2 diabetes mellitus: Indian multicentric randomized trial - START Study
by: T V Devarajan, et al.
Published: (2017-01-01)

Comparative Effect of Insulin Sensitizers and Statin on Metabolic Profile and Ultrasonographical Score in Non Alcoholic Fatty Liver Disease
by: Himanshu Rana, et al.
Published: (2016-08-01)

Pioglitazone: A boon we know less about
by: Dilip Gude
Published: (2013-01-01)

Comparison of efficacy of add-on therapy of vildagliptin versus pioglitazone among Type 2 Diabetes Mellitus patients inadequately controlled on dual therapy of metformin plus sulfonylurea
by: Kirandeep Kaur
Published: (2014-02-01)

Determination of Pioglitazone Hydrochloride in Tablets by High-Performance Liquid Chromatography
by: AMR Lotfy Saber
Published: (2008-12-01)

Usage of pioglitazone at Medanta, the Medicity
by: Ambrish Mithal, et al.
Published: (2014-01-01)

Pioglitazone: Indian perspective
by: Rishi Shukla, et al.
Published: (2011-01-01)